Fed. Circ. Affirms Invalidity Of Tyco Restoril Patent
The three-judge panel affirmed a New Jersey federal court’s grant of summary judgment to Mutual, now called URL Pharma Inc., after finding two claims of Tyco’s U.S. Patent Number 5,211,954 were invalid due to obviousness.
Tyco, along with Mallinckrodt Inc., lodged the suit in March 2007 in response to Mutual’s filing of...
To view the full article, register now.